Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.03B P/E - EPS this Y 29.20% Ern Qtrly Grth -
Income -186.64M Forward P/E -20.90 EPS next Y 30.30% 50D Avg Chg 3.00%
Sales 482.26M PEG -0.94 EPS past 5Y - 200D Avg Chg 23.00%
Dividend N/A Price/Book N/A EPS next 5Y 12.00% 52W High Chg -10.00%
Recommedations 1.80 Quick Ratio 1.89 Shares Outstanding 137.98M 52W Low Chg 141.00%
Insider Own 34.75% ROA -13.98% Shares Float 97.84M Beta 1.47
Inst Own 67.15% ROE -411.75% Shares Shorted/Prior 12.36M/11.30M Price 17.14
Gross Margin 64.32% Profit Margin -38.70% Avg. Volume 1,246,875 Target Price 23.41
Oper. Margin -25.40% Earnings Date May 7 Volume 722,282 Change -3.65%
About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Alphatec Holdings, Inc. News
04/17/24 ATEC to Report First Quarter Financial Results on May 7, 2024
03/27/24 Alphatec Holdings, Inc.'s (NASDAQ:ATEC) Intrinsic Value Is Potentially 60% Above Its Share Price
03/10/24 3 Sexy Small-Cap Stocks to Add Sizzle to Your Portfolio
03/08/24 Director Quentin Blackford Acquires 20,000 Shares of Alphatec Holdings Inc (ATEC)
03/04/24 Alphatec Holdings Inc CFO John Koning Sells 121,601 Shares
03/01/24 Insider Sell: EVP of Sales David Sponsel Sells 32,365 Shares of Alphatec Holdings Inc (ATEC)
02/29/24 Alphatec Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
02/28/24 Alphatec Holdings, Inc. (NASDAQ:ATEC) Q4 2023 Earnings Call Transcript
02/27/24 Alphatec Holdings Inc (ATEC) Reports Robust Revenue Growth and Margin Expansion in FY 2023
02/27/24 Alphatec: Q4 Earnings Snapshot
02/27/24 ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights
01/29/24 ATEC to Present at Upcoming Conferences
01/08/24 ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance
01/08/24 Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan
12/19/23 ATEC to Present at the 2024 J.P. Morgan Healthcare Conference
12/09/23 Alphatec Holdings (NASDAQ:ATEC) shareholders have earned a 38% CAGR over the last five years
11/12/23 With 54% ownership of the shares, Alphatec Holdings, Inc. (NASDAQ:ATEC) is heavily dominated by institutional owners
11/07/23 Alphatec Holdings, Inc. (NASDAQ:ATEC) Q3 2023 Earnings Call Transcript
11/06/23 Alphatec Holdings Inc (ATEC) Reports 32% Revenue Growth in Q3 2023, Raises Full Year EBITDA Guidance
11/06/23 ATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance
ATEC Chatroom

User Image Stock_Titan Posted - 2 days ago

$ATEC ATEC to Report First Quarter Financial Results on May 7, 2024 https://www.stocktitan.net/news/ATEC/atec-to-report-first-quarter-financial-results-on-may-7-e83ch1p1i1f9.html

User Image G101SPM Posted - 03/28/24

$ATEC $13.80 bid. DAC (dollar average cost) $16.87. EXIT $20.00/11.4.24. NEWS: Needham analyst David Saxon maintains Alphatec Holdings(ATEC) with a Buy and raises the price target from $22 to $23.

User Image erevnon Posted - 03/28/24

Needham maintains Alphatec Holdings $ATEC at Buy and raises the price target from $22 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image QuixoteDeez Posted - 03/27/24

@Wigglyick go $ATEC vs ofix

User Image SmartInsider Posted - 03/26/24

Alphatec Holdings Inc- $ATEC US ranked positive on March 19th, 2024 Learn more: https://www.smartinsider.com/stock-of-the-week/atec-us-ranked-positive-on-march-19th-2024/

User Image winona2sd Posted - 03/22/24

$ATEC

User Image Sarahsays Posted - 03/21/24

$ATEC Needham Maintains Buy on Alphatec Holdings, Raises Price Target to $22

User Image Sarahsays Posted - 03/21/24

$ATEC Canaccord Genuity Reiterates Buy on Alphatec Holdings, Maintains $25 Price Target

User Image erevnon Posted - 4 weeks ago

Canaccord Genuity reiterates Alphatec Holdings $ATEC at Buy and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image DonCorleone77 Posted - 4 weeks ago

$ATEC Alphatec sees FY27 revenue at $1B Sees FY27 adjusted EBITDA at $180M and free cash flow of $65M. Says the company is set to grow its revenue by 41%, up from 23% revenue growth CAGR outlined in FY22. Comments taken from Investor Day presentation slides yesterday.

User Image erevnon Posted - 4 weeks ago

Needham maintains Alphatec Holdings $ATEC at Buy and raises the price target from $19 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image G101SPM Posted - 1 month ago

$ATEC $14.21 +0.71. UPDATE: Alphatec at conference says revenue commitment in 2027 is $1 bln, which is a 20% revenue CAGR.

User Image DonCorleone77 Posted - 1 month ago

$ATEC Alphatec to host investor day Investor Day to be held in New York on March 19 at 3 pm.

User Image G101SPM Posted - 1 month ago

$ATEC $14.10 bid. DAC (dollar average cost) $16.87 (2.9.24). EXIT $20.00 FACT: Alphatec jumps to highs (long range plan update call started at 3 p.m. ET.

User Image DonCorleone77 Posted - 1 month ago

$ATEC Alphatec to host investor day Investor Day to be held in New York on March 19 at 3 pm.

User Image insiderbuyingselling Posted - 1 month ago

$ATEC new insider buying: 15000 shares. http://insiderbuyingselling.com/?t=ATEC

User Image erevnon Posted - 1 month ago

Needham reiterates Alphatec Holdings $ATEC at Buy and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image G101SPM Posted - 1 month ago

$ATEC $13.33 bid. DAC (dollar average cost) $16.87 (2.9.24). EXIT $20.00. UPDATE: Needham analyst David Saxon reiterates Alphatec Holdings(ATEC) with a Buy and maintains $19 price target.

User Image StockInvest_us Posted - 1 month ago

Signal alert: $ATEC - Possible Runner https://stockinvest.us/l/3fScbJGchb

User Image RL213 Posted - 1 month ago

@winona2sd terry rich isn’t linked to Atec once Pat took over. Unless you’re saying because one company does it then another must follow the same path. Do you research. Pat has taken a company with all “me too”products and created a new approach to spine fusion w/ the help of Dr. Pimenta and other leading renown surgeons. If you don’t see the vision, that’s fine, move on and invest elsewhere. I agree there are games being played but won’t like a child and point fingers unjustly. You sound like a bitter X employee(Nuvasive Days I assume)

User Image insiderbuyingselling Posted - 1 month ago

$ATEC new insider buying: 20000 shares. http://insiderbuyingselling.com/?t=ATEC

User Image winona2sd Posted - 1 month ago

$ATEC

User Image winona2sd Posted - 1 month ago

$ATEC

User Image Sarahsays Posted - 1 month ago

$ATEC ATEC: We Expect Upside Throughout 2024; Investor Day Up Next ATEC's 4Q23 revenue was in line with its preannouncement (see here) and management reiterated its 2024 revenue guidance. Under ATEC's prior adjustments, EBITDA beat consensus in 4Q23 and for its 2024 guidance. Importantly, management expects to approach free cash flow breakeven in 2H24. Our sense is revenue guidance does not assume contribution from competitive reps being hired currently, which likely leaves room for upside throughout the year. We reiterate our Buy rating and believe next month's Investor Day could serve as a catalyst. NEEDHAM

User Image winona2sd Posted - 1 month ago

$ATEC

User Image insiderbuyingselling Posted - 1 month ago

$ATEC new insider selling: 121601 shares. http://insiderbuyingselling.com/?t=ATEC

User Image insiderbuyingselling Posted - 1 month ago

$ATEC new insider selling: 11825 shares. http://insiderbuyingselling.com/?t=ATEC

User Image G101SPM Posted - 1 month ago

$ATEC $13.42 bid. DAC $16.87 (2.16.24). EXIT $20.00. Retain Position. UPDATE: HC Wainwright & Co. analyst Sean Lee reiterates Alphatec Holdings(ATEC) with a Buy and maintains $20 price target

User Image TipRanks Posted - 1 month ago

TipRanks’ ‘Perfect 10’ List: Unveiling 2 High-Scoring Stocks With Strong Growth Potential https://www.tipranks.com/news/article/tipranks-perfect-10-list-unveiling-2-high-scoring-stocks-with-strong-growth-potential $ATEC $ML

User Image Manipulation13F Posted - 1 month ago

$ATEC 🤑🤑🤑🤑🤑🤑🤑

Analyst Ratings
Needham Buy Mar 28, 24
Canaccord Genuity Buy Mar 20, 24
Needham Buy Mar 20, 24
Needham Buy Mar 13, 24
HC Wainwright & Co. Buy Mar 4, 24
Needham Buy Feb 28, 24
Needham Buy Dec 19, 23
Morgan Stanley Overweight Nov 14, 23
Stifel Buy Nov 7, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Sponsel David EVP, SALES EVP, SALES Feb 01 Sell 16.47 36,620 603,131 639,918 02/05/24
Hunsaker Craig E EVP, PEOPLE & CULTUR.. EVP, PEOPLE & CULTURE Feb 01 Sell 16.46 39,056 642,862 1,266,069 02/05/24
Lish Scott CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Feb 01 Sell 16.47 25,210 415,209 518,457 02/05/24
Sponsel David EVP, SALES EVP, SALES Dec 21 Sell 15 2,500 37,500 557,780 12/26/23
Miles Patrick CEO CEO Sep 25 Sell 12.66 179,375 2,270,888 5,452,736 09/27/23
Miles Patrick CEO CEO Sep 18 Sell 13.42 180,000 2,415,600 5,632,111 09/20/23
Bakst Evan Director Director Aug 23 Sell 14.92 8,700 129,804 1,089,038 08/24/23
Pritzker Jennifer N. 10% Owner 10% Owner Aug 08 Buy 15.11 5,750 86,882 6,000 08/10/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Jun 27 Sell 18 107,029 1,926,522 1,120,427 06/28/23
Segal Paul Director Director Jun 12 Sell 15.15 71,329 1,080,634 100,000 06/16/23
TULLIS JAMES L L Director Director May 17 Option 3.5 261,178 914,123 658,267 05/18/23
TULLIS JAMES L L Director Director May 15 Option 3.5 261,177 914,120 575,283 05/16/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC May 15 Sell 15.29 58,238 890,459 1,227,456 05/16/23
Berkowitz Mortimer III Director Director May 12 Option 3.5 107,937 377,780 663,058 05/12/23
Miles Patrick CEO CEO May 10 Option 3.5 269,842 944,447 5,872,606 05/12/23
Segal Paul 10% Owner 10% Owner May 10 Sell 14.88 167,496 2,492,340 171,329 05/12/23
L-5 Healthcare Partners, LLC 10% Owner 10% Owner May 10 Sell 14.88 1,700,000 25,296,000 11,081,538 05/12/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Apr 24 Sell 15.85 28,311 448,729 1,285,694 04/24/23
Koning John Todd CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Apr 20 Sell 16.42 16,500 270,930 415,552 04/24/23
Miles Patrick CEO CEO Apr 04 Sell 15.86 353 5,599 5,607,764 04/06/23
TULLIS JAMES L L Director Director Mar 08 Sell 16.12 30,000 483,600 467,974 03/09/23
WOODS WARD W JR Director Director Mar 06 Option 3.5 539,683 1,888,890 2,174,604 03/08/23
Miles Patrick CEO CEO Mar 06 Sell 5348.23 180,000 962,681,400 5,748,117 03/08/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Feb 27 Sell 15.23 126,033 1,919,483 1,346,828 03/01/23
Lish Scott SVP, DEVELOPMENT SVP, DEVELOPMENT Feb 27 Option 3.5 13,493 47,226 444,015 03/01/23
Lish Scott SVP, DEVELOPMENT SVP, DEVELOPMENT Feb 27 Sell 14.76 25,372 374,491 430,522 03/01/23
Koning John Todd CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Feb 27 Sell 14.76 22,500 332,100 432,052 03/01/23
Koning John Todd CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Feb 22 Sell 14.20 13,068 185,566 470,644 02/23/23
Lish Scott SVP, DEVELOPMENT SVP, DEVELOPMENT Feb 21 Sell 14.2 22,070 313,394 453,034 02/23/23
L-5 Healthcare Partners, LLC - - Feb 17 Option 3.5 2,346,032 8,211,112 13,343,865 02/21/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Feb 17 Sell 14.04 65,716 922,653 1,472,861 02/21/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Feb 17 Option 3.5 134,921 472,224 1,570,916 02/21/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Feb 09 Sell 14 60,000 840,000 1,435,995 02/10/23
L-5 Healthcare Partners, LLC - - Jan 25 Option 3.5 2,000,000 7,000,000 11,530,346 01/26/23
Miles Patrick CEO CEO Jan 20 Sell 13.16 180,000 2,368,800 5,301,633 01/24/23
Miles Patrick CEO CEO Jan 17 Sell 13.23 180,000 2,381,400 5,481,633 01/19/23
TULLIS JAMES L L Director Director Dec 16 Sell 10.59 50,000 529,500 497,974 12/20/22
Sponsel David EVP, SALES EVP, SALES Dec 05 Sell 9.88 10,000 98,800 556,983 12/05/22
L-5 Healthcare Partners, LLC - - Nov 09 Option 3.5 1,000,000 3,500,000 9,242,761 11/10/22
Sponsel David EVP, SALES EVP, SALES Nov 07 Sell 9.25 10,000 92,500 566,690 11/09/22
Mowry David H Director Director Aug 29 Sell 7.85 4,370 34,304 91,973 08/29/22
Altman Elizabeth Ann Director Director Aug 17 Sell 9.06 8,009 72,562 40,431 08/17/22
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Aug 15 Sell 9.42 40,795 384,289 1,251,174 08/17/22
Pritzker Jennifer N. 10% Owner 10% Owner Aug 09 Buy 7.99 8,100 64,719 6,000 08/11/22
Snider Brian EVP, Marketing EVP, Marketing Jun 15 Option 2 50,000 100,000 676,821 06/17/22
Segal Paul 10% Owner 10% Owner Jun 14 Buy 6.91 100,000 691,000 338,825 06/16/22
Hunsaker Craig E EVP, People/Culture.. EVP, People/Culture & GC Jun 13 Sell 7.16 60,000 429,600 1,301,729 06/15/22
TULLIS JAMES L L Director Director Jun 13 Buy 6.76 7,500 50,700 187,558 06/15/22
Berkowitz Mortimer III Director Director Jun 09 Buy 7.20 16,000 115,200 555,121 06/13/22
Segal Paul 10% Owner 10% Owner Jun 09 Buy 7.14 71,329 509,289 238,825 06/13/22